150 related articles for article (PubMed ID: 10081824)
1. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
Vitale G; Corona P; Loriga M; Paglietti G
Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824
[TBL] [Abstract][Full Text] [Related]
2. Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity.
Corona P; Vitale G; Loriga M; Paglietti G
Farmaco; 2000 Feb; 55(2):77-86. PubMed ID: 10782376
[TBL] [Abstract][Full Text] [Related]
3. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S
Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661
[TBL] [Abstract][Full Text] [Related]
4. Quinoxaline chemistry. Part 11. 3-Phenyl-2[phenoxy- and phenoxymethyl]-6(7) or 6,8-substituted quinoxalines and N-[4-(6(7)-substituted or 6,8-disubstituted-3-phenylquinoxalin-2-yl)hydroxy or hydroxymethyl] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase.
Corona P; Vitale G; Loriga M; Paglietti G; Costi MP
Farmaco; 1998 Jul; 53(7):480-93. PubMed ID: 9836461
[TBL] [Abstract][Full Text] [Related]
5. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
Loriga M; Fiore M; Sanna P; Paglietti G
Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity.
Sanna P; Carta A; Loriga M; Zanetti S; Sechi L
Farmaco; 1998 Jul; 53(7):455-61. PubMed ID: 9836457
[TBL] [Abstract][Full Text] [Related]
7. Quinoxaline chemistry. Part 7. 2-[aminobenzoates]- and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
Loriga M; Piras S; Sanna P; Paglietti G
Farmaco; 1997 Mar; 52(3):157-66. PubMed ID: 9212450
[TBL] [Abstract][Full Text] [Related]
8. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
Alleca S; Corona P; Loriga M; Paglietti G; Loddo R; Mascia V; Busonera B; La Colla P
Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
Corona P; Carta A; Loriga M; Vitale G; Paglietti G
Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
Zarranz B; Jaso A; Aldana I; Monge A
Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
[TBL] [Abstract][Full Text] [Related]
11. Quinoxaline chemistry. Part 10. Quinoxaline 10-oxa-analogues of trimetrexate (TMQ) and of 5,8-dideazafolic acid. Synthesis and evaluation of in vitro anticancer activity.
Vitale G; Corona P; Loriga M; Paglietti G
Farmaco; 1998 Feb; 53(2):150-9. PubMed ID: 9604322
[TBL] [Abstract][Full Text] [Related]
12. Quinoxaline chemistry. Part 4. 2(R)-anilinoquinoxalines as nonclassical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity.
Loriga M; Fiore M; Sanna P; Paglietti G
Farmaco; 1995 May; 50(5):289-301. PubMed ID: 7626163
[TBL] [Abstract][Full Text] [Related]
13. Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity.
Piras S; Loriga M; Paglietti G
Farmaco; 2004 Mar; 59(3):185-94. PubMed ID: 14987981
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
15. Quinoxaline chemistry. Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity.
Loriga M; Vitale G; Paglietti G
Farmaco; 1998 Feb; 53(2):139-49. PubMed ID: 9604321
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
[TBL] [Abstract][Full Text] [Related]
17. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
[TBL] [Abstract][Full Text] [Related]
18. Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues--homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
Piras S; Loriga M; Paglietti G
Farmaco; 2002 Jan; 57(1):1-8. PubMed ID: 11902640
[TBL] [Abstract][Full Text] [Related]
19. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
Carta A; Sanna P; Gherardini L; Usai D; Zanetti S
Farmaco; 2001 Dec; 56(12):933-8. PubMed ID: 11829113
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Lee YB; Gong YD; Kim DJ; Ahn CH; Kong JY; Kang NS
Bioorg Med Chem; 2012 Feb; 20(3):1303-9. PubMed ID: 22226981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]